LDR Spine Receives FDA OK to Market Spine Products

LDR Spine, which has developed implantable systems that make it easier to perform spine surgeries, has gotten clearance from the FDA to market two fusion spine products in the U.S. The FDA cleared the Austin, Texas, company to market the Easyspine posterior osteosynthesis system and the BF+ complementary synthetic bone substitute, which is comprised of beta tri-calcium phosphate featuring biocompatibility characteristics.

Austin Business Journal (http://austin.bizjournals.com/austin/stories/2005/02/21/daily16.html)